DexCom Future Growth
Future criteria checks 4/6
DexCom is forecast to grow earnings and revenue by 18.4% and 14.9% per annum respectively. EPS is expected to grow by 16.8% per annum. Return on equity is forecast to be 27.8% in 3 years.
Key information
18.4%
Earnings growth rate
16.8%
EPS growth rate
Medical Equipment earnings growth | 18.3% |
Revenue growth rate | 14.9% |
Future return on equity | 27.8% |
Analyst coverage | Good |
Last updated | 01 May 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 6,055 | 1,116 | 1,170 | 1,539 | 17 |
12/31/2025 | 5,152 | 895 | 907 | 1,250 | 22 |
12/31/2024 | 4,330 | 708 | 719 | 1,127 | 22 |
3/31/2024 | 3,802 | 639 | 584 | 802 | N/A |
12/31/2023 | 3,622 | 542 | 512 | 749 | N/A |
9/30/2023 | 3,403 | 377 | 500 | 747 | N/A |
6/30/2023 | 3,198 | 358 | 466 | 771 | N/A |
3/31/2023 | 3,023 | 293 | 416 | 754 | N/A |
12/31/2022 | 2,910 | 341 | 305 | 670 | N/A |
9/30/2022 | 2,793 | 244 | 261 | 643 | N/A |
6/30/2022 | 2,673 | 230 | 216 | 597 | N/A |
3/31/2022 | 2,572 | 258 | 95 | 486 | N/A |
12/31/2021 | 2,449 | 217 | 53 | 443 | N/A |
9/30/2021 | 2,319 | 577 | 140 | 509 | N/A |
6/30/2021 | 2,170 | 562 | 101 | 409 | N/A |
3/31/2021 | 2,027 | 530 | 236 | 502 | N/A |
12/31/2020 | 1,927 | 550 | 277 | 476 | N/A |
9/30/2020 | 1,821 | 231 | 264 | 447 | N/A |
6/30/2020 | 1,716 | 205 | 209 | 394 | N/A |
3/31/2020 | 1,601 | 148 | 131 | 305 | N/A |
12/31/2019 | 1,476 | 101 | 135 | 315 | N/A |
9/30/2019 | 1,351 | -171 | 51 | 205 | N/A |
6/30/2019 | 1,222 | -170 | 39 | 167 | N/A |
3/31/2019 | 1,128 | -130 | 53 | 144 | N/A |
12/31/2018 | 1,032 | -127 | 56 | 123 | N/A |
9/30/2018 | 915 | 43 | 64 | 131 | N/A |
6/30/2018 | 833 | -5 | 53 | 110 | N/A |
3/31/2018 | 761 | -33 | 25 | 83 | N/A |
12/31/2017 | 719 | -50 | N/A | 92 | N/A |
9/30/2017 | 669 | -48 | N/A | 64 | N/A |
6/30/2017 | 633 | -65 | N/A | 51 | N/A |
3/31/2017 | 599 | -88 | N/A | 57 | N/A |
12/31/2016 | 573 | -66 | N/A | 56 | N/A |
9/30/2016 | 533 | -57 | N/A | 54 | N/A |
6/30/2016 | 490 | -80 | N/A | 49 | N/A |
3/31/2016 | 445 | -64 | N/A | 45 | N/A |
12/31/2015 | 402 | -58 | N/A | 49 | N/A |
9/30/2015 | 356 | -58 | N/A | 46 | N/A |
6/30/2015 | 319 | -20 | N/A | 40 | N/A |
3/31/2015 | 285 | -23 | N/A | 29 | N/A |
12/31/2014 | 259 | -22 | N/A | 24 | N/A |
9/30/2014 | 227 | -26 | N/A | 20 | N/A |
6/30/2014 | 201 | -27 | N/A | 10 | N/A |
3/31/2014 | 178 | -31 | N/A | 5 | N/A |
12/31/2013 | 160 | -30 | N/A | 2 | N/A |
9/30/2013 | 142 | -36 | N/A | -13 | N/A |
6/30/2013 | 122 | -47 | N/A | -20 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: DC4's forecast earnings growth (18.4% per year) is above the savings rate (0.7%).
Earnings vs Market: DC4's earnings (18.4% per year) are forecast to grow faster than the German market (15.4% per year).
High Growth Earnings: DC4's earnings are forecast to grow, but not significantly.
Revenue vs Market: DC4's revenue (14.9% per year) is forecast to grow faster than the German market (5.5% per year).
High Growth Revenue: DC4's revenue (14.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: DC4's Return on Equity is forecast to be high in 3 years time (27.8%)